Report Categories
View AllRecent Articles
View All
PSAN Public reports quarterly results as preferred dividend coverage remains stable amid rate environment
ABT Abbott Laboratories reports narrow Q1 2026 EPS miss as positive investor sentiment pushes shares up 14 percent
Dianthus DNTH Investment Thesis Dianthus Therapeutics Inc posts 303 EPS miss with no revenue
BSX Boston Sci tops Q4 2025 EPS estimates and posts 20 percent revenue growth shares drop 5 percent today
ATT Inc T PreEarnings Preview Q1 2026 Expectations And Key Metrics To Watch
How Elanco ELAN stacks up against analyst expectations Drifts Lower 20260511
RiverNorth RIV Stock Price Target RiverNorth posts 163 EPS on solid 363T revenue
Imax Corporation IMAX Crushes Q1 2026 Estimates EPS 017 Tops Views
McKinsey Reshapes Partner Pay Shifting to Greater Equity Share in PostAI Era
Trumps China Visit Reignites Uncertainty Over Chip Exports and Rare Earths Access
The Federal Reserve Is Running Out of Room to Justify Rate Cuts
XPLR XIFR Down 244 How Low Could It Go 20260515
Utah UTMD Slips 072 Testing 6008 Support 20260515
BridgeBio BBIO Climbs 335 Resistance at 7162 in Focus 20260520
Cambium CMBM Stock RangeBound at 040 Resistance at 042 20260521
Turkey Removes Direct Trade Restriction with Armenia Signaling Potential Economic Shift
Bharat Dynamics Q4 2026 Net Profit Slumps 59 YoY to 113 Crore Final Dividend of 040 Announced
Golds Consolidation Viewed as Healthy Amid Persistent Fiat Currency Pressures
GitHubs AI Coding Ambitions Face Outage Setbacks as Competition Intensifies
April Jobs Report Preview Labor Market Cooling but Showing Resilience Amid Economic Challenges
The Hype Trap Why FOMO Could Be the Worst Reason to Chase a SpaceX IPO
Indian Bond Bull Market May Pause but Still Has Room to Run Analyst Suggests
CBZ Q1 2026 Earnings Earnings Surpass Estimates with 124 EPS Surprise
UGRO Q3 2025 Earnings Significant EPS Miss Raises Concerns
CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained
RBRK Q1 2026 Earnings Surprise Profit Beats Expectations as Cost Discipline Drives Results
FCX Q1 2026 Earnings Copper Giant Beats EPS Estimates but Shares Edge Lower
RRX Q1 2026 Earnings Earnings Beat on Solid Execution Amid Mixed Market Conditions
Edgewise Therapeutics EWTX Holds Steady Near Support Amid Biotech Trading Lull
M3Brigade Acquisition VI Corp Warrants MBVIW Hold Steady at 040 Amid Low Volatility
Vox Royalty Corp VOXR Surges Over 5 Key Support and Resistance Levels in Focus
Acurx Pharmaceuticals ACXP Nudges Higher as Stock Approaches Resistance
Atour Lifestyle Holdings ATAT Slips 275 as Selling Pressure Tests Key Support Zone